Related Experiment Video
Updated: Jun 27, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling
Marc S Raab1, Iris Breitkreutz, Giovanni Tonon
1LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. marc_raab@dfci.harvard.edu
Abstract:
Targeting protein kinase C (PKC) isoforms by the small molecule inhibitor enzastaurin has shown promising preclinical activity in a wide range of tumor cells. We further delineated its mechanism of action in multiple myeloma (MM) cells and found a novel role of beta-catenin in regulating growth and survival of tumor cells. Specifically, inhibition of PKC leads to rapid accumulation of beta-catenin by preventing the phosphorylation required for its proteasomal degradation. Microarray analysis and small-interfering RNA (siRNA)-mediated gene silencing in MM cells revealed that accumulated beta-catenin activates early endoplasmic reticulum stress signaling via eIF2alpha, C/EBP-homologous protein (CHOP), and p21, leading to immediate growth inhibition. Furthermore, accumulated beta-catenin contributes to enzastaurin-induced cell death. Sequential knockdown of beta-catenin, c-Jun, and p73, as well as overexpression of beta-catenin or p73 confirmed that accumulated beta-catenin triggers c-Jun-dependent induction of p73, thereby conferring MM cell apoptosis. Our data reveal a novel role of beta-catenin in endoplasmic reticulum (ER) stress-mediated growth inhibition and a new proapoptotic mechanism triggered by beta-catenin on inhibition of PKC isoforms. Moreover, we identify p73 as a potential novel therapeutic target in MM. Based on these and previous data, enzastaurin is currently under clinical investigation in a variety of hematologic malignancies, including MM.
Insights
Enzastaurin inhibits protein kinase C (PKC) in multiple myeloma, causing beta-catenin accumulation. This triggers endoplasmic reticulum stress and apoptosis, revealing p73 as a therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Protein kinase C (PKC) inhibitors, like enzastaurin, show preclinical anti-cancer activity.
- The precise mechanisms of enzastaurin in multiple myeloma (MM) require further elucidation.
- Beta-catenin's role in cancer cell growth and survival is complex and context-dependent.
Purpose of the Study:
- To investigate the mechanism of action of enzastaurin in multiple myeloma cells.
- To identify the role of beta-catenin in mediating enzastaurin's effects.
- To explore novel therapeutic targets in multiple myeloma based on enzastaurin's action.
Main Methods:
- Treatment of multiple myeloma cells with enzastaurin.
- Analysis of beta-catenin accumulation and phosphorylation.
- Microarray analysis and siRNA-mediated gene silencing to assess signaling pathways.
- Investigation of downstream targets including eIF2alpha, CHOP, p21, c-Jun, and p73.
Main Results:
- Enzastaurin inhibits PKC, leading to beta-catenin accumulation by preventing its degradation.
- Accumulated beta-catenin induces endoplasmic reticulum (ER) stress via eIF2alpha, CHOP, and p21, causing growth inhibition.
- Beta-catenin accumulation triggers c-Jun-dependent induction of p73, promoting apoptosis in MM cells.
- p73 is identified as a key mediator of enzastaurin-induced apoptosis.
Conclusions:
- Beta-catenin plays a novel role in ER stress-mediated growth inhibition and apoptosis induction upon PKC inhibition.
- Enzastaurin induces MM cell death through a novel beta-catenin/c-Jun/p73 apoptotic pathway.
- p73 represents a potential novel therapeutic target for multiple myeloma treatment.
Related Concept Videos
MAPK Signaling Cascades
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
PI3K/mTOR/AKT Signaling Pathway
Non-Canonical Wnt Signaling Pathways
cAMP-dependent Protein Kinase Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

